Cardiac biomarker indicates fluid overload in dialysis patients

Nephrologists must consider fluid overload effects when prescribing dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The fluid overload biomarker, N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP), previously known as a `cardiac biomarker` in dialysis patients, is an important component of managing patients with kidney disease.

Read the whole article on Physorg

More from Physorg